跳至主要内容
临床试验/KCT0004853
KCT0004853招募中未知

A phase II study of extended-field proton therapy alone after with or without endoscopic submucosal dissection for patients with superficial esophageal cancer

ational Cancer Center0 个研究点目标入组 77 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
77

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • histologically proven thoracic or gastroesophageal junctional superficial esophageal cancer
  • - no evidence of lymph node metatasis in endoscopic US, chest CT, and PET-CT
  • - ECOG performance status 0-2
  • - one of those among lymphovascular invasion (+), submucosal invasion (+) or positive vertical resection margin in submucosal dissection specimen
  • - unresectable lesion with submucosal dissection, but patient refused to undergo curative surgery
  • - Informed consent

排除标准

  • - Recurrent esophageal cancer
  • - a history of previous treatment for esophageal cancer including local or systemic therapy
  • - presence of other malignancies except cured skin squamous cell carcinoma, skin basal cell carcinoma and carcinoma in situ in uterine cervix.
  • - Uncontrolled mental illness, severe head trauma, chronic alcoholics or drug addictions

研究者

发起方
ational Cancer Center

相似试验